Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1052304]Researchers: Dr Jonathan Lane (Principal investigator)
Brief description The focus of these studies are two important types of brain proteins that have been implicated in various symptoms associated with schizophrenia. The aim is to exploit two emerging paradigms of drug action at these brain proteins that will allow us to target them in a more selective manner. In particular, these studies will provide a starting point for safer, more effective treatments for schizophrenia.
Funding Amount $AUD 415,218.31
Funding Scheme Career Development Fellowships
Notes RD Wright Biomedical CDF
- nhmrc : 1052304
- PURL : https://purl.org/au-research/grants/nhmrc/1052304
